mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
0.19 |
0.1 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.2 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |